• TCAIM Control of OGDH and Mitochondrial Metabolism

  2026-08-29

  The reference study identifies TCAIM as a mitochondrial DNAJC co-chaperone that specifically binds native OGDH and promotes its reduction through HSPA9 and LONP1. This mechanism expands the role of mitochondrial proteostasis from protein folding and quality control to selective regulation of a rate-limiting metabolic enzyme, with consequences for OGDH complex activity and carbohydrate catabolism.

• AmpliFold Capture-and-Release for LFA Sensitivity

  2026-08-28

  The reference study introduces AmpliFold, a triggered capture-and-release architecture that gives analyte complexes an additional high-affinity rebinding opportunity in lateral flow assays. In a HER2 model, the strategy improved analytical sensitivity by managing capture area, receptor density, linker design, and nanoparticle behavior rather than relying solely on faster antibody association kinetics.

• NVP-BGJ398 Phosphate in Reliable Cell Assays

  2026-08-28

  Learn how NVP-BGJ398 phosphate (SKU A3673) can support reproducible FGFR pathway inhibition in viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects formulation, assay design, pathway validation, and vendor selection to published FGFR3 evidence.

• CFTRinh-172 Workflows for CFTR Research

  2026-08-27

  CFTRinh-172 is a rapid, selective CFTR inhibitor for separating channel activity from trafficking and surface-abundance effects in epithelial models. This guide combines practical assay workflows with reference-study insights for cystic fibrosis research, intestinal secretion models, and mechanistic troubleshooting.

• HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody

  2026-08-27

  Build sensitive red-channel detection into neuroblastoma nanocarrier studies with a goat anti-rabbit IgG secondary antibody designed for ICC/IF, tissue imaging, flow cytometry, and ELISA workflows. This guide translates the iRGD-modified red blood cell membrane photodynamic therapy study into practical staining, validation, and troubleshooting decisions.

• A 83-01 in hiPSC Intestinal Organoid Assays

  2026-08-26

  A 83-01 is an ALK-5 inhibitor that can help dissect TGF-β control of intestinal epithelial behavior in hiPSC-derived organoids. This article connects receptor-level pathway perturbation with the 2025 organoid pharmacokinetic model, emphasizing assay design, controls, and interpretation rather than simply describing organoid culture.

• S Tag Peptide (A6007): Workflow and QC Guide

  2026-08-26

  S Tag Peptide (SKU A6007) is a soluble, 15-amino-acid fusion-tag sequence for recombinant protein detection, antibody-based purification, and protein solubility improvement. Use it in workflows with compatible anti-S-Tag reagents and aqueous handling; avoid ethanol-containing preparations and long-term storage of solutions.

• Phenothiazines, ROS, and Autophagy in Macrophages

  2026-08-25

  The 2025 Frontiers in Immunology study identifies phenothiazines as host-directed antibacterial leads that strengthen macrophage control of intracellular bacteria through coordinated lysosomal activity, autophagy, and reactive oxygen species accumulation. Perphenazine also reduced infection-associated lesions and inflammation in a Salmonella Typhimurium model, supporting further mechanistic evaluation while leaving questions about specificity, toxicity, and clinical transferability unresolved.

• Sodium Oxamate: A Causal Tool for Lactate Biology

  2026-08-25

  Sodium Oxamate is more than a Warburg effect inhibitor: it can help distinguish lactate-dependent signaling from secondary effects of altered glycolysis. This article translates recent TNBC radioresistance findings into a rigorous assay framework for cancer metabolism research and tumor bioenergetics studies.

• Gramine Drives Ferroptosis in TNBC via CUL3–MTDH

  2026-08-24

  A 2026 study identifies Gramine as a selective suppressor of triple-negative breast cancer through a previously uncharacterized CUL3–MTDH regulatory axis. By combining target-engagement assays, ferroptosis rescue experiments, gene knockdown, and xenograft models, the authors connect CUL3 inhibition and MTDH stabilization with lipid-peroxidation-associated cancer cell death.

• BH3-Mimetic Targeting in Glioblastoma

  2026-08-24

  Koessinger and colleagues show that glioblastoma is unusually dependent on anti-apoptotic BCL-xL and MCL-1, including in stem-like tumor-cell populations. Their results support sequential BH3-mimetic targeting as a strategy for exploiting apoptotic priming while highlighting the need to validate molecular dependency and treatment schedule in clinically relevant models.

• Cycloheximide: Translation Blockade in Apoptosis Assays

  2026-08-23

  Cycloheximide is a protein biosynthesis inhibitor for separating translation-dependent effects from direct apoptotic signaling. This guide connects ribosomal elongation control with protein turnover studies, caspase activity measurement, and interpretation of BAK-focused apoptosis assays.

• Gepotidacin Mechanisms in Staphylococcus aureus Gyrase

  2026-08-22

  Gibson and colleagues define how gepotidacin inhibits Staphylococcus aureus gyrase through a mechanism that differs from conventional fluoroquinolones. Biochemical assays and high-resolution structures show potent inhibition of DNA topology, selective stabilization of single-stranded cleavage complexes, and a binding mode that may help explain activity against fluoroquinolone-resistant bacteria.

• LY2886721: Threshold-Aware BACE1 Assays

  2026-08-22

  Explore LY2886721 as a BACE inhibitor through a threshold-aware framework that connects amyloid beta reduction with synaptic function, biomarker selection, and experimentally actionable assay design.

• SW033291: A Decision Framework for 15-PGDH Studies

  2026-08-21

  SW033291 is a potent 15-PGDH inhibitor for dissecting prostaglandin E2 elevation, stem-cell behavior, and regenerative repair. This evidence-led guide connects biochemical assay design with hematopoietic and muscle research while clarifying what recent GLP-1 receptor agonist findings do—and do not—demonstrate about the compound.

8556 records 1/571 page Next 12345 下5页 Last page